Home > Financial Ratios > WOCKHARDT

WOCKHARDT
Core EBITDA Growth

    Back to All Ratios
WOCKHARDT is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
Best 1M Momentum Small Cap Stocks
COMMUNITY POLL
for WOCKHARDT
Please provide your vote to see the results

WOCKHARDT Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Core EBITDA Growth(%) 272.95-45.29-29.87360.87-56.28

What is the latest Core EBITDA Growth ratio of WOCKHARDT ?

The latest Core EBITDA Growth ratio of WOCKHARDT is 272.95 based on Mar2025 Consolidated results.
Year Core EBITDA Growth
Mar2025272.95
Mar2024-45.29
Mar2023-29.87
Mar2022360.87
Mar2021-56.28

How is Core EBITDA Growth of WOCKHARDT Trending?

Years Core EBITDA Growth % Change
Mar2025 272.95
Positive
Mar2024 -45.29
Negative
Mar2023 -29.87
Negative
Mar2022 360.87
Positive
Mar2021 -56.28 -

Other Financial Ratios of WOCKHARDT


Compare Core EBITDA Growth ratio of peers of WOCKHARDT

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
WOCKHARDT ₹32,998.9 Cr 28.9% 43.3% 32.2% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹432,096.0 Cr -2.4% 3% 9.6% Stock Analytics
DIVIS LABORATORIES ₹176,807.0 Cr -3.3% 3.5% 4.9% Stock Analytics
TORRENT PHARMACEUTICALS ₹148,718.0 Cr -2% 5% 43.1% Stock Analytics
CIPLA ₹112,971.0 Cr -0% 6.9% -4.5% Stock Analytics
DR REDDYS LABORATORIES ₹108,752.0 Cr -0.3% -3.8% 7.3% Stock Analytics


WOCKHARDT Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
WOCKHARDT

28.9%

43.3%

32.2%

SENSEX

-0.5%

-3.3%

-7.6%


You may also like the below Video Courses